BJOG An International Journal of Obstetrics & Gynaecology · 2005 · 40 citations · 21 references
PharmacyPediatricsPharmacoeconomicsClinical EpidemiologyCost-effectiveness AnalysisPharmacoeconomic ModelingChild Disease PreventionCost-effectiveness ModelingPediatric Antibiotic TherapyPerinatal Infection PreventionGroup B Streptococcal PreventionGroup B Streptococcal ScreeningHealth Economics Of ScreeningIntrapartum Antibiotic ProphylaxisMaternal-intrapartum Antibiotic ProphylaxisOutcome MeasuresSocietal Perspective AnalysisTreatment Strategies
OBJECTIVE: To estimate the costs and effects of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal (GBS) disease in the Netherlands. The treatment strategies include a risk-based strategy, a screening-based strategy, a combined screening/risk-based strategy and the current Dutch guideline. DESIGN: Cost-effectiveness analysis based on decision model. SETTING: Obstetric care system in the Netherlands. POPULATION/SAMPLE: Hypothetical cohort of 200,000 neonates. METHODS: A decision analysis model was used to compare the costs and effects of different treatment strategies with no treatment. Baseline estimates were derived from literature and a survey among parents of children affected by GBS disease. The analysis was performed from a societal perspective, and costs and effects were discounted at a percentage of 3%. Main outcome measures Cost per quality adjusted of life-year (QALY). RESULT: The risk-based strategy will prevent 352 cases of early-onset GBS for 5.0 million Euros, indicating a cost-effectiveness ratio of 7600 Euros per QALY gained. The combined screening risk-based strategy has comparable results. The current Dutch guideline resulted in lower effects for higher costs. The screening-based strategy shows the highest reduction in cases of early-onset GBS, however, at a cost-effectiveness ratio of 59,300 Euros per QALY gained. Introducing the polymerase chain reaction (PCR) test may lead to a more favourable cost-effectiveness ratio. CONCLUSION: In the Dutch system, the combined screening/risk-based strategy and the risk-based strategy have reasonable cost-effectiveness ratios. If it becomes feasible to add the PCR test, the cost-effectiveness of the combined screening/risk-based strategy may even be more favourable.
21
Rapid Detection of Group B Streptococci in Pregnant Women at Delivery
Michel G. Bergeron, Danbing Ke, Christian Ménard et al. · New England Journal of Medicine · 2000 · 295 citations · Full text
Medicine, Microbiology, Obstetrics +15